Biodesix Cash Flow Statement (2019-2026) | BDSX

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-11.40M-14.64M-13.18M-15.60M-12.97M-13.65M-16.44M-18.76M-13.36M-9.56M-9.20M-13.55M-10.17M-10.63M-8.40M-10.82M-11.62M-9.12M-4.03M-8.18M
Depreciation and Depletion (Quarter)
0.20M0.30M0.43M0.40M0.40M0.40M0.42M0.30M0.30M0.30M-0.44M0.90M0.90M1.00M0.96M0.90M0.90M0.90M0.84M0.90M
Share-based Compensation (Quarter)
0.54M1.39M1.27M1.35M1.37M1.17M2.08M2.28M1.06M0.95M1.08M2.64M1.22M1.51M1.26M0.97M1.04M1.05M1.07M1.11M
Gains from Sales and Divestitures (Quarter)
0.14M0.10M0.36M0.09M0.53M0.08M0.71M0.02M0.01M0.00M0.03M0.02M0.01M0.04M0.04M0.04M
Gains from Investment Securities (Quarter)
0.30M2.87M0.12M2.87M2.71M0.29M-0.06M0.31M-0.06M1.57M0.13M4.02M-0.02M2.44M1.84M-0.61M-0.02M
Asset Writedowns and Impairment (Quarter)
-0.04M0.54M-0.42M0.01M0.03M-0.01M0.08M0.10M0.07M0.07M0.10M0.07M0.03M0.01M-0.06M0.01M
Non-cash Items (Quarter)
1.27M1.35M6.29M1.20M1.67M1.63M1.49M1.62M1.56M0.77M0.96M0.56M1.52M1.72M0.72M0.03M0.00M0.15M0.02M2.30M
Cash from Operations (Quarter)
1.09M-7.79M-10.20M-13.10M-9.59M-10.33M-11.95M-7.69M0.94M-3.84M-12.28M-15.31M-18.57M-10.67M-4.10M-8.60M-6.57M-8.88M0.78M-10.17M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.28M0.45M0.77M0.75M0.76M0.63M0.46M0.33M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.78M0.80M0.85M0.91M0.90M0.89M0.90M0.79M0.78M0.78M0.98M1.42M1.41M1.49M1.45M1.44M1.44M1.41M1.39M1.40M
Change in Working Capital
Change in Receivables (Quarter)
-13.09M-2.50M0.87M0.08M1.68M-0.99M0.74M0.03M-0.61M1.76M3.54M2.34M0.33M-1.86M1.00M-0.90M-0.18M5.22M-3.61M0.49M
Change in Accured Expenses (Quarter)
-3.71M0.19M1.84M-1.30M0.11M0.55M-0.13M-2.03M3.27M-1.48M0.76M-1.23M0.56M0.62M1.69M-1.94M2.34M0.49M0.97M-2.34M
Other Working Capital Changes (Quarter)
-0.23M-0.42M0.09M-0.27M-0.42M-0.04M-0.21M-0.54M-0.81M1.11M-0.27M0.42M0.22M0.04M-1.40M-0.02M-0.10M-0.22M0.51M1.37M
Investing Activities
Capital Expenditures (Quarter)
0.28M0.96M0.53M0.26M0.33M0.78M1.93M7.68M6.42M5.84M2.98M0.23M1.93M0.23M0.84M0.07M0.05M0.05M0.09M0.08M
Cash from Investing Activities (Quarter)
-0.35M-1.04M-0.64M-0.35M-0.38M-0.81M-1.99M-7.71M-6.47M-5.88M-3.00M-0.27M-2.00M-0.29M-0.88M-0.14M-0.10M-0.07M-0.10M-0.14M
Financing Activities
Other financing activities (Quarter)
0.00M-0.01M0.07M0.03M0.10M3.60M0.80M-0.88M0.91M0.02M0.02M-0.31M0.32M0.01M0.02M-0.58M0.58M0.03M
Cash from Financing Activities (Quarter)
0.28M0.40M-4.36M-2.83M22.13M-2.27M41.85M-2.42M-2.33M12.15M21.73M0.79M51.30M0.14M-0.18M0.10M9.79M4.82M1.71M16.90M
Additional items
Change in Cash (Quarter)
1.02M-8.44M-15.20M-16.29M12.16M-13.41M27.91M-17.81M-7.87M2.43M6.44M-14.79M30.73M-10.81M-5.16M-8.64M3.13M-4.12M2.38M6.58M
Free Cash Flow (Quarter)
0.81M-8.75M-10.73M-13.36M-9.92M-11.11M-13.88M-15.36M-5.48M-9.68M-15.27M-15.54M-20.50M-10.90M-4.93M-8.68M-6.62M-8.93M0.69M-10.25M
Net Cash Flow (Quarter)
1.02M-8.44M-15.20M-16.29M12.16M-13.41M27.91M-17.81M-7.87M2.43M6.44M-14.79M30.73M-10.81M-5.16M-8.64M3.13M-4.12M2.38M6.58M